Catheter ablation as first-line treatment for ventricular tachycardia in patients with structural heart disease and preserved left ventricular ejection fraction: a systematic review and meta-analysis

Catheter ablation as first-line treatment for ventricular tachycardia in patients with structural heart disease and preserved left ventricular ejection fraction: a systematic review and meta-analysis

Abstract In this systematic review and meta-analysis, we aim to evaluate the efficacy and safety of catheter ablation as the first-line treatment of ventricular tachycardia (VT) in patients with structural heart disease (SHD) and preserved left ventricular ejection fraction (LVEF). Patients with SHD...

Full description

Bibliographic Details
Main Authors: Amir Askarinejad, Arash Arya, Moein Zangiabadian, Zahra Ghahramanipour, Hamed Hesami, Danial Farmani, Kimiya Ghanbari Mardasi, Erfan Kohansal, Majid Haghjoo
Format: Article
Language:English
Published: Nature Portfolio 2024-08-01
Series:Scientific Reports
Subjects:
Ventricular tachycardia
Implantable cardioverter-defibrillators
Catheter ablation
Structural heart disease
Preserved LVEF
Online Access:https://doi.org/10.1038/s41598-024-69467-4

Internet

https://doi.org/10.1038/s41598-024-69467-4

Similar Items